
Application note
RPE differentiation
Full-length, human recombinant Biolaminin 521 (LN521) provides a defined, animal-origin–free substrate that supports efficient generation of retinal pigment epithelial (RPE) cells from human pluripotent stem cells — yielding cells with native RPE features and suitability for research or clinical applications
What’s inside
- Defined LN521-based protocol for deriving RPE from hESCs under clinically compliant, feeder-free conditions
- High seeding efficiency, cell migration, and formation of uniform RPE monolayers
- RPE cells showing native morphology, pigmentation, polarization, marker expression, and phagocytic activity
- Evidence that derived RPE cells integrate in vivo, survive long-term, and rescue photoreceptor function post-transplantation